ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,753Medicare Part D Prescriptions Filled, Including Refills

Rank: 152 out of 551

$557K Total Retail Price of All Prescriptions

Rank: 70 out of 551

656 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 656 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 8,508 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 494 414 1 1
GABAPENTIN 372 287 2 3
METFORMIN HCL 339 259 3 2
SYNTHROID 338 276 4 11
AMLODIPINE BESYLATE 299 250 5 4
LEVOTHYROXINE SODIUM 274 244 6 9
METOPROLOL SUCCINATE 257 193 7 23
TRAMADOL HCL-ACETAMINOPHEN 253 143 8 18
LOSARTAN POTASSIUM 202 195 9 6
GLIMEPIRIDE 191 165 10 16
ZOLPIDEM TARTRATE 183 128 11 27
ENALAPRIL MALEATE 179 140 12 5
AMLODIPINE BESYLATE-BENAZEPRIL 171 148 13 42
ISOSORBIDE MONONITRATE ER 165 154 14 21
FUROSEMIDE 159 144 15 13
SERTRALINE HCL 157 112 16 43
ATENOLOL 156 130 17 12
DONEPEZIL HCL 153 153 18 50
FAMOTIDINE 133 95 19 31
OMEPRAZOLE 118 91 20 7
METOPROLOL TARTRATE 114 84 21 17
RANITIDINE HCL 112 69 22 8
DIOVAN 111 100 23 57
NAMENDA 105 105 24 94
CLOPIDOGREL 98 94 25 30
LANSOPRAZOLE 97 60 26 72
LYRICA 95 61 27 86
LANTUS 92 68 28 28
DIOVAN HCT 92 67 28 71
CARVEDILOL 90 86 30 22
LOSARTAN-HYDROCHLOROTHIAZIDE 89 74 31 10
PLAVIX 86 76 32 33
BUMETANIDE 85 56 33 108
ATORVASTATIN CALCIUM 85 68 33 29
DICLOFENAC SODIUM 84 71 35 99
AZITHROMYCIN 82 55 36 55
CLOTRIMAZOLE-BETAMETHASONE 81 62 37 49
MEGESTROL ACETATE 75 71 R 38 115
GLIPIZIDE 73 61 39 20
TAMSULOSIN HCL 72 71 40 38
FENOFIBRATE 69 37 41 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 57 42 119
PAROXETINE HCL 66 61 43 77
PANTOPRAZOLE SODIUM 65 55 44 36
ZETIA 65 53 44 69
COUMADIN 65 43 44 88
PREDNISOLONE 62 40 47 118
OLANZAPINE 61 52 48 274
DIPYRIDAMOLE 59 58 R 49 76
ALENDRONATE SODIUM 59 54 49 19
MECLIZINE HCL 58 47 51 56
LISINOPRIL 57 48 52 14
WARFARIN SODIUM 55 33 53 46
AVELOX 54 45 54 148
TRILIPIX 52 36 55 158
CIPROFLOXACIN HCL 50 41 56 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.